Skip to main content

Table 3 IMP diagnoses were highly associated with real-world decisions

From: Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohort

Association

Univariate analysis

Multivariate analysis

 

OR (95 % CI)

p value

OR (95 % CI)

p value

Real-world decision (intervention vs. surveillance) at follow-up

Initial ICG recommendation

5.6 (3.7 − 8.5)

<0.0001

3.7 (2.4 − 5.8)

<0.0001

Initial IMP diagnosis

16.8 (9.0 − 34.4)

<0.0001

11.4 (6.0 − 23.7)

<0.0001

Actual patient outcome (benign vs. malignant) at follow-up

Initial ICG recommendation

8.5 (3.9 − 22.3)

<0.0001

2.5 (1.0 − 7.4)

0.066

Initial IMP diagnosis

47.4 (23.8 − 102.4)

<0.0001

35.8 (17.4 − 80.0)

<0.0001

  1. Univariate and multivariate analyses indicated that IMP diagnoses were highly associated with real-world intervention and surveillance decisions and predictive of actual patient outcomes